Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
193,539,047
-
Total 13F shares
-
182,409,125
-
Share change
-
+3,129,908
-
Total reported value
-
$15,984,411,685
-
Put/Call ratio
-
78%
-
Price per share
-
$87.69
-
Number of holders
-
519
-
Value change
-
+$294,129,377
-
Number of buys
-
262
-
Number of sells
-
215
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) as of Q4 2020
As of 31 Dec 2020 BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) had 519 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 182,409,125 shares of stock of the company.
Largest 10 holders included Capital Research Global Investors, PRIMECAP MANAGEMENT CO/CA/, VANGUARD GROUP INC, BlackRock Inc., Dodge & Cox, BAKER BROS. ADVISORS LP, Clearbridge Investments, LLC, JANUS HENDERSON GROUP PLC, STATE STREET CORP, and AMERIPRISE FINANCIAL INC.
This table shows 520 institutional shareholders of the security as of 31 Dec 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.